Skip to main content Skip to navigation
BB700 Mouse Anti-Human CLEC-2A (PILAR)
Product Details
Down Arrow Up Arrow


BD OptiBuild™
CLEC2A; KACL; PILAR; INPE5792; UNQ5792
Human (Tested in Development)
Mouse IgG1, κ
Human CLEC-2A Recombinant Protein
Flow cytometry (Qualified)
0.2 mg/ml
AB_2872640
Aqueous buffered solution containing ≤0.09% sodium azide.
RUO


Preparation And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BB700 under optimal conditions that minimize unconjugated dye and antibody.

Recommended Assay Procedures

For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).

748206 Rev. 2
Antibody Details
Down Arrow Up Arrow
705518

The 705518 monoclonal antibody specifically recognizes C-type lectin domain family 2 member A (CLEC-2A) which is also known as Proliferation-induced lymphocyte-associated receptor (PILAR) or Keratinocyte-associated C-type lectin (KACL). CLEC-2A is a ~35 kDa type II transmembrane glycoprotein that is encoded by CLEC2A which belongs to the C-type lectin superfamily. The extracellular region of CLEC-2A contains one C-type lectin domain. CLEC-2A (PILAR) is expressed on keratinocytes and can activate NK cells through binding to their surface KLRF2 molecules. It is also expressed on activated CD8+ T cells and can costimulate proliferative responses upon interaction with CD161.

748206 Rev. 2
Format Details
Down Arrow Up Arrow
BB700
The BD Horizon Brilliant™ Blue 700 (BB700) Dye is part of the BD Horizon Brilliant™ Blue family of dyes. This tandem fluorochrome is comprised of a polymer-technology dye donor with an excitation maximum (Ex Max) of 476-nm and an acceptor dye with an emission maximum (Em Max) at 695-nm. Driven by BD innovation, BB700 is designed to be excited by the blue laser (488-nm) and detected using an optical filter centered near 695-nm (e.g., a 695/20-nm bandpass filter). The donor dye can be excited by the Violet (405 nm) laser and the acceptor dye can be excited by the red (627–640 nm) laser resulting in cross-laser excitation and fluorescence spillover. BB700 Reagents are significantly brighter than equivalent PerCP or PerCP-Cy5.5 reagents and are less sensitive to photobleaching. In addition, BB700 shows much less excitation by the violet (407-nm) laser resulting in less spillover. BB700 has minimal yellow green (562-nm) excitation and is ideal for instruments with both blue (488-nm) and yellow green (562-nm) lasers. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.
BB700
476 nm
695 nm
748206 Rev.2
Citations & References
Down Arrow Up Arrow
View product citations for antibody "748206" on CiteAb
No Citations Found

No Citations Are Available for this Product

748206 Rev. 2

Please refer to Support Documents for Quality Certificates

 

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

 

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Refer to manufacturer's instructions for use and related User Manuals and Technical Data Sheets before using this product as described.

Comparisons, where applicable, are made against older BD technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.